NEW YORK (GenomeWeb News) – Navigenics and 23andMe issued an open, joint letter to Nature yesterday in response to an opinion article on direct-to-consumer genetic testing that appeared in the journal last month. ...
Relative Finder takes advantage of autosomal DNA by looking for shared segments with other 23andMe customers, which indicate a common ancestor. We list your closest matches first, but also let you sort and filter on other criteria you ...
Google has given money to its founder's[Sergei Brin] wife's[Anne Wojcicki] firm 23AndMe, which in turn has given money (or other consideration) to Airship Ventures, owned by Google itself (it would appear) and by Google vendor, ...
Unfortunately, Nature could not publish the letter because of space restrictions, so 23andMe and Navigenics decided to publish the letter to our respective sites. —. Dear Editor: We read with interest the Opinion piece entitled “An ...
That's why starting next week, on Thursday November 19th , we will begin offering our service as two distinct products to better meet the needs of our customers: The 23andMe Ancestry Edition and The 23andMe Health Edition. ...
Personal genomics company 23andMe announced yesterday on its blog (and in an email to customers) of impending changes to its product line. Until now 23andMe has offered only two products: its $399 full scan, and a $99 Research ...
Looking for more information on
23andme?? You have come to the right
place with the latest information about 23andme including videos, news and the most recent blog posts featuring 23andme plus hollywood and tv celebrity news.
23andMe is a privately held personal genomics and biotechnology company based in Mountain View, California[1] that is developing new methods and technologies which can enable consumers to understand their own genetic information. In December 2007, three companies, 23andMe, Navigenics and deCODE, announced the availability of $999 to $2500 tests for genome-wide, select single nucleotide polymorphisms. 23andme dropped their price to $399 in Sep 2008[2]. Google has invested $3.9M in 23andMe, whose co-founder Anne Wojcicki is married to Google co-founder Sergey Brin.[3]Genentech is also reported to have invested in 23andMe.[4]
Thomas Söderqvist wrote:
There has not been much news about the company yet (see Blaine Bettinger’s blog The Genetic Genealogist and Attila Csordas’ Pimm), but my guess is that we will hear more about it in the near future. Whatever its future prospects, however, it’s already a good example of how converging technologies ... are emerging at the start-up company level.
The marriage between Sergey Brin and Anne Wojcicki is thus not just a romantic Silicon Valley story; it’s also today’s counterpart to traditional politically motivated marital alliances and gives a new meaning to the concept of converging technologies.[5]
Kevin Kelleher in GigaOM writes: " A case could be made that there is a good reason for Google to make this deal. And although I realize I may end up regretting it, I am going to make that case.... an investment in 23andMe lets Google chart yet another collision coarse [sic] with Microsoft’s ambitions. ... If Google wants to really organize the world information, it needs to consider DNA, the most personal of data. And what 23andMe is purporting to sell is the ultimate in navel gazing."[4]
In April 2008, New York State's Department of Health sent warning letters to six online genetic testing companies, including 23andme, notifying them that they can neither offer New York state residents genetic tests without a permit nor without authorization from a doctor.[6] In June 2008, California's Dept of Public Health issued 'cease and desist' letters to 23andme, among other genetic testing companies, notifying them to stop offering tests until they provide proof of state and federal clinical lab certification and until genetics test results are only issued when ordered directly by a physician.[7] The company responded that they were already in compliance with California law and would continue to operate in California. However, much of the issue of compliance relies on whether the genetics testing is regarded as 'educational' as 23andme argues, or 'diagnostic', in which case the process is bound by much stricter regulations. Currently, only 25 states permit direct-to-consumer (DTC) genetics tests without restriction.[8]
In August 2008, two companies that offer consumers information about their genes, 23andme and Navigenics, have received licenses that will allow them to continue to do business in California.[9]
In 2008, Time magazine named 23andMe's DNA-testing service "Invention of the Year" for pioneering retail genomics. [10]
Navigenics, 23andMe Respond To DTC Genetics Opinion Paper - GenomeWeb Daily News
Navigenics, 23andMe Respond To DTC Genetics Opinion Paper GenomeWeb Daily News By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Navigenics and 23andMe issued an open, joint letter to Nature yesterday in response to an opinion ...
Gene testing firm goes titsup Register 23andMe, which offers a similar service, recently had to cut an undisclosed number of jobs. Luckily the company is partly funded by co-founder Anne ...
Wotshotrightnow
combines the latest search traffic data from the
internet's two most popular
search engines, Google and Yahoo to bring you the very latest
search trends.
No matter your question, what is
23andme, who is 23andme, where is
23andme or how is
23andme then wotshotrightnow.com can answer it.